Cargando…
A Reappraisal of Thymosin Alpha1 in Cancer Therapy
Thymosin alpha1 (Tα1), an endogenous peptide first isolated from the thymic tissue in the mid-sixties, has gained considerable attention for its immunostimulatory activity that led to its application to diverse pathological conditions, including cancer. Studies in animal models and human patients ha...
Autores principales: | Costantini, Claudio, Bellet, Marina M., Pariano, Marilena, Renga, Giorgia, Stincardini, Claudia, Goldstein, Allan L., Garaci, Enrico, Romani, Luigina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742685/ https://www.ncbi.nlm.nih.gov/pubmed/31555601 http://dx.doi.org/10.3389/fonc.2019.00873 |
Ejemplares similares
-
COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections
por: Bellet, Marina M., et al.
Publicado: (2023) -
Thymosin α1 protects from CTLA-4 intestinal immunopathology
por: Renga, Giorgia, et al.
Publicado: (2020) -
Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease
por: Renga, Giorgia, et al.
Publicado: (2019) -
Tryptophan Co-Metabolism at the Host-Pathogen Interface
por: Costantini, Claudio, et al.
Publicado: (2020) -
To Be or Not to Be a Pathogen: Candida albicans and Celiac Disease
por: Renga, Giorgia, et al.
Publicado: (2019)